Syndax Pharmaceuticals SNDX
NASDAQ SNDX
$9.59 +0.10 (+1.05%)
At close: Nov 11, 2026 · 4:00 PM EST

Syndax Pharmaceuticals (SNDX) Cash & Current Investments (2015 - 2026)

Updated

Syndax Pharmaceuticals (SNDX) recorded Cash & Current Investments of $427.1 million in Q3 2026, down 2.0% from $435.98 million a year earlier and down 22.0% from the prior quarter.

Analysis

Syndax Pharmaceuticals (SNDX) Cash & Current Investments (2015 - 2026) Analysis & Trends

At the end of FY2025, Syndax Pharmaceuticals reported Cash & Current Investments of $394.07 million, down 31.2% from FY2024.

  • Annual Cash & Current Investments has a five-year compound annual growth rate of 6.1% (FY2020 to FY2025).
  • Across earlier years, Cash & Current Investments came in at $572.88 million in FY2024 (+0.4%), $570.7 million in FY2023 (+19.9%), $475.8 million in FY2022 (+8.1%) and $440.05 million in FY2021 (+50.1%).
  • Quarterly Cash & Current Investments has ranged from $337.95 million in Q3 2022 to $572.88 million in Q4 2024 over the past five years.
  • On a year-over-year basis, Cash & Current Investments rose in five of the last eight quarters, with an average decline of 0.9%.
  • Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 50.1% in Q4 2021, against a decline of 31.3% in Q1 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $547.86 million (Q2 2026), $352.06 million (Q1 2026) and $394.07 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.23 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 10.77 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 9.65 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 505.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 8.17 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 6.44 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 14.27 Bn
10 Syndax Pharmaceuticals 854.00 Mn -867.10 Mn 69.30 Mn 427.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 427.10 Mn
Jun 30, 2026 547.86 Mn
Mar 31, 2026 352.06 Mn
Dec 31, 2025 394.07 Mn
Sep 30, 2025 435.98 Mn
Jun 30, 2025 455.23 Mn
Mar 31, 2025 512.20 Mn
Dec 31, 2024 572.88 Mn
Sep 30, 2024 389.61 Mn
Jun 30, 2024 425.10 Mn
Mar 31, 2024 434.58 Mn
Dec 31, 2023 570.70 Mn
Sep 30, 2023 363.56 Mn
Jun 30, 2023 398.80 Mn
Mar 31, 2023 432.39 Mn
Dec 31, 2022 475.80 Mn
Sep 30, 2022 337.95 Mn
Jun 30, 2022 366.91 Mn
Mar 31, 2022 398.05 Mn
Dec 31, 2021 440.05 Mn
API Access

Syndax Pharmaceuticals Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=SNDX&period=max&api_key=YOUR_API_KEY